Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
10/2003
10/16/2003WO2003038073A3 Method for enhancing keratinocyte stem cells
10/16/2003WO2003037918A3 Pyranosone dehydratase from phanerochaete chrysosporium
10/16/2003WO2003029426A3 Human and murine cytokine polypeptides
10/16/2003WO2003029413A3 A novel g protein-coupled receptor, gave 10
10/16/2003WO2003016545A3 Process for the production of scleroglucan
10/16/2003WO2003016525A9 Process for producing alcohol from starch
10/16/2003WO2003016496A3 Zinc finger binding domains for cnn
10/16/2003WO2003014359A3 A fusion protein
10/16/2003WO2003010288A3 Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same
10/16/2003WO2003004520A3 Mycobacterial antigens expressed during latency
10/16/2003WO2003002709A3 Novel technology for genetic mapping
10/16/2003WO2003000930A3 Nucleotide sequences involved in plant disease resistance
10/16/2003WO2002101050A3 Process for the preparation of d-pantothenic acid and/or salts thereof
10/16/2003WO2002101018A3 Methods for inducing reversible stasis
10/16/2003WO2002098899A3 CHDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
10/16/2003WO2002097043A3 Wnv core protein/capsid interacting protein and uses of the same
10/16/2003WO2002090493A3 Δ4-desaturase genes and uses thereof
10/16/2003WO2002079428A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/16/2003WO2002070655A3 Mouse cytokine receptor
10/16/2003WO2002068677A8 Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer
10/16/2003WO2001088148A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/16/2003US20030196219 Involves storing the Agrobacterium in the cold for some period of time so as to increase transformation efficiency
10/16/2003US20030196217 Desaturase genes, enzymes encoded thereby, and uses thereof
10/16/2003US20030196212 An isolated nucleic acid sequence encoding a polypeptide specific bind to the receptor; treating infertility, contraception disorders, sexual dysfunction, nervous system disorders, psychiatric disorders, liver disorders
10/16/2003US20030195349 H. pylori flbA polypeptides, immunogenic and vaccinating compositions comprising H. pylori flbA polypeptides, and compositions for detection of an infection comprising H. pylori flbA polypeptides
10/16/2003US20030195346 An isolated amino acid sequences are expressed by a cell; for use as human secreted proteins such as human insulin, interferon, Factor VIII, human growth hormones
10/16/2003US20030195338 Concatameric immunoadhesion
10/16/2003US20030195337 UL16 binding protein 4
10/16/2003US20030195336 Nucleic acid and polypeptide compositions encoding lepidopteran-toxic polypeptides
10/16/2003US20030195156 Tumor necrosis factors; cytokines; immunoglobulins; autoimmune diseases
10/16/2003US20030195146 Prepared by culturing Beauveria in medium; substances thus obtained are less toxic, specifically inhibit acyl-Coenzyme A: cholesterol acyltransferase, and inhibit formation of oil droplets in macrophages
10/16/2003US20030195117 Without using any chemically synthesized pesticides.
10/16/2003US20030194800 For immunization, generation of packaging cell lines, and production of immunogenic compositions
10/16/2003US20030194798 For diagnositic, therapeutic, research, and drug discovery applications
10/16/2003US20030194796 Novel cyclodextrin glucanotransferase, process for producing the same and process for producing cyclodextrin by using this enzyme
10/16/2003US20030194790 DNA sequences coding for ester-group-cleaving enzymes
10/16/2003US20030194787 Fermentative preparation process for and crystal forms of cytostatics
10/16/2003US20030194785 Making an erythromycin derivative of given formula by fermenting an organism capable of producing erythromycin in the presence of a carboxylic acid of given formula
10/16/2003US20030194784 Recombinant polyhydroxyalkanoate synthases are derived from multifunctional fatty acid synthases or polyketide synthases that generate hydroxyacyl acids capable of forming polylactones via polyhydroxyalkanoate synthase
10/16/2003US20030194782 Methods for recombinant peptide production
10/16/2003US20030194761 Novel nucleic acid sequences encoding human fibroblast growth factor-like polypeptides
10/16/2003US20030194757 Specific synthetic peptide sequences used in place of partially purified proteins, infected cells or cell lysates
10/16/2003US20030194756 Peptides for detection of antibody to Ehrlichia equi
10/16/2003US20030194732 For treating neoplastic diseases by testing responsiveness to interferons
10/16/2003US20030194727 Screening nucleic acids that encode different artificial, chimeric proteins to identify a chimeric protein that alters a phenotypic trait of a cell or organism
10/16/2003US20030194726 Thermus oshimai nucleic acid polymerases
10/16/2003US20030194720 Human ion channels
10/16/2003US20030194413 Methods and compositions employing red rice fermentation products
10/16/2003US20030194408 Antibody which specifically binds to at least two variants of an epitope of an HIV-1 Tat protein
10/16/2003US20030194406 P-cadherin as a target for anti-cancer therapy
10/16/2003US20030194404 Gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders
10/16/2003US20030194391 Vaccine
10/16/2003CA2481437A1 Motif-grafted hybrid polypeptides and uses thereof
10/16/2003CA2481318A1 Identification of virulence associated regions rd1 and rd5 leading to improve vaccine of m. bovis bcg and m. microti
10/16/2003CA2481090A1 Novel pancortin-pablo protein interactions and methods of use thereof
10/16/2003CA2481039A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/16/2003CA2480786A1 Recombinant p. falciparum merozoite protein-142 vaccine
10/16/2003CA2480728A1 Microfluidic particle-analysis systems
10/16/2003CA2480504A1 Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell
10/16/2003CA2479927A1 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
10/16/2003CA2478930A1 Epitope constructs comprising antigen presenting cell targeting mechanisms
10/16/2003CA2477421A1 Novel promoter
10/15/2003EP1352977A2 Novel Desulfitobacterium strain for the degradation of chloroalkenes
10/15/2003EP1352966A2 Method for producing L-amino acid
10/15/2003EP1352964A1 Process for producing substance by using microbial catalyst
10/15/2003EP1352962A1 186 human secreted proteins
10/15/2003EP1352961A1 Synovial cell protein
10/15/2003EP1352958A1 Gene disrupted yeast
10/15/2003EP1352954A2 Method of preparing culture support factor from insects
10/15/2003EP1352953A2 Fungal inoculum, method for its preparation and methods for its utilisation for the treatment of waste water with high content in organic material
10/15/2003EP1352092A2 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis
10/15/2003EP1352083A2 Compositions and methods for detecting target microorganisms in a sample
10/15/2003EP1352075A2 Maize yellow stripe1 and related genes
10/15/2003EP1352068A2 Bacillus thuringiensis insecticidal proteins
10/15/2003EP1352063A2 Receptor nucleic acids and polypeptides
10/15/2003EP1352062A2 Improved growth hormone molecules
10/15/2003EP1352057A2 Lipolytic enzyme variant
10/15/2003EP1352056A2 Polypeptides
10/15/2003EP1352054A2 Aspergillus ochraceus 11 alpha hydrolase and oxidoreductase
10/15/2003EP1352050A1 Microbiological method for producing amides
10/15/2003EP1351985A2 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors
10/15/2003EP1351983A2 Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof
10/15/2003EP1351979A1 Regulated activation of cell-membrane receptors by metal-chelating agonists
10/15/2003EP1351974A2 Using viruses to detect or purify proteins
10/15/2003EP1351970A2 Compositions and methods for the release of nucleic acid molecules from solid matrices
10/15/2003EP1351968A1 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
10/15/2003EP1351967A2 Compositions and methods for the therapy and diagnosis of lung cancer
10/15/2003EP1351699A1 Methods for improved diagnosis and treatment of mycobacterial infections
10/15/2003EP0814663B1 NOVEL PESTICIDAL COMPOSITION AND method
10/15/2003EP0689595B1 Plant promoter, microorganisms and plant cells containing a unit for the expression of a protein of interest comprising said promoter
10/15/2003CN1449447A Butinol I esterase
10/15/2003CN1449446A Streptococcus antigens
10/15/2003CN1449442A Process for producing biopterins
10/15/2003CN1449441A Yeast transformant producing recombinant human parathyroid hormone and method for producing the hormone
10/15/2003CN1449410A Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
10/15/2003CN1449399A Polycyclic xanthones as antibiotics
10/15/2003CN1448510A High-efficiency expression of recombination human basic fibroblast growth factor
10/15/2003CN1448506A Mutation penicillin ring enlargement enzyme and process preparing 7-ADCA using same
10/15/2003CN1448504A Construction and application of engineering bacterium LZ-17
10/15/2003CN1448503A Prep. of functional red rice powder without citrinin
1 ... 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 ... 1489